DPS expands into US with acquisition
The terms of the acquisition have not been disclosed.
Biometics was founded in 1991 by Dr Stephen Fitzpatrick, who will join the DPS board of directors when the acquisition is complete. Biometics is an engineering consultancy specialising in biotechnology including biopharmaceuticals and biofuels and employs 20 people at its design office in Framingham.
Biometics has an established client list including Dow Chemicals, Abbott Laboratories, Immunogen, Acambis, Celltech and Astra Zeneca and has recently secured the prestigious bio-processing facility project for the University of Massachusetts.